Tonghe Pharmaceutical: Agomelatine and Opioid Drugs Obtained Registration Certificates from the South Korean Ministry of Food and Drug Safety.

Tonghe Pharmaceutical announced that it has recently received the registration certificates for Agomelatine and Opicapone from the South Korean Ministry of Food and Drug Safety. Agomelatine is used for the treatment of adult depression, while Opicapone is a COMT inhibitor mainly used clinically for treating Parkinson's disease and Parkinson's syndrome. The company's Agomelatine and Opicapone active pharmaceutical ingredients have obtained access qualifications to the South Korean market, which will play a positive role in further expanding the company's international market business.